Factor XIII: More than just a fibrin stabilizer for the burn patient? A matched-pair analysis.

Burns Coagulation Factor XIII Intensive care Wound healing

Journal

JPRAS open
ISSN: 2352-5878
Titre abrégé: JPRAS Open
Pays: Netherlands
ID NLM: 101680420

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 04 02 2023
accepted: 15 04 2023
medline: 8 6 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: epublish

Résumé

Acquired factor XIII deficiency is an underestimated risk in patients with large surface burns, which potentially exposes these patients to prolonged bleeding and delayed wound healing if undetected. A retrospective matched-pair analysis of the burn registry of the Department of Plastic, Aesthetic, Hand, and Reconstructive Surgery of Hannover Medical School was performed from 2018 to 2023. A total of 18 patients were included. Acquired factor XIII deficiency was not statistically significant correlated with age, sex, or body mass index. Patients who developed acquired factor XIII deficiency had a significantly longer hospital stay (72.8 days) compared with those in the matched group (46.4 days), although burn depths, total body surface area, and Abbreviated Burn Severity Index were not statistically correlated with factor XIII deficiency. Little is known about acquired factor XIII deficiency in patients with burns. Factor XIII supplementation may improve hemostasis, wound healing, and general outcome while reducing the patient's exposure to blood products.

Sections du résumé

Background UNASSIGNED
Acquired factor XIII deficiency is an underestimated risk in patients with large surface burns, which potentially exposes these patients to prolonged bleeding and delayed wound healing if undetected.
Methods UNASSIGNED
A retrospective matched-pair analysis of the burn registry of the Department of Plastic, Aesthetic, Hand, and Reconstructive Surgery of Hannover Medical School was performed from 2018 to 2023.
Results UNASSIGNED
A total of 18 patients were included. Acquired factor XIII deficiency was not statistically significant correlated with age, sex, or body mass index. Patients who developed acquired factor XIII deficiency had a significantly longer hospital stay (72.8 days) compared with those in the matched group (46.4 days), although burn depths, total body surface area, and Abbreviated Burn Severity Index were not statistically correlated with factor XIII deficiency.
Conclusions UNASSIGNED
Little is known about acquired factor XIII deficiency in patients with burns. Factor XIII supplementation may improve hemostasis, wound healing, and general outcome while reducing the patient's exposure to blood products.

Identifiants

pubmed: 37288428
doi: 10.1016/j.jpra.2023.04.002
pii: S2352-5878(23)00012-8
pmc: PMC10242619
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1-8

Informations de copyright

© 2023 The Author(s).

Références

Biochemistry. 1974 Feb 12;13(4):750-6
pubmed: 4811064
Burns. 2007 Jun;33(4):435-40
pubmed: 17382476
Methods Mol Biol. 2017;1646:277-293
pubmed: 28804836
J Burn Care Rehabil. 2001 Jan-Feb;22(1):1-5
pubmed: 11227678
Thromb Haemost. 2009 Oct;102(4):765-71
pubmed: 19806264
Transfus Med Hemother. 2016 Sep;43(5):365-373
pubmed: 27781024
Burns. 2011 Jun;37(4):559-65
pubmed: 21194843
Burns. 2017 Mar;43(2):249-257
pubmed: 27600982
BJS Open. 2021 Mar 5;5(2):
pubmed: 33893737
Transfus Apher Sci. 2018 Dec;57(6):724-730
pubmed: 30446212
Burns. 2013 May;39(3):389-94
pubmed: 22673117
Ann Plast Surg. 2003 Apr;50(4):367-72
pubmed: 12671377
Blood Rev. 2016 Nov;30(6):461-475
pubmed: 27344554
Int J Mol Sci. 2021 Mar 17;22(6):
pubmed: 33802692
Surg Neurol. 2000 Sep;54(3):260-4; discussion 264-5
pubmed: 11118574
Crit Care. 2022 Mar 24;26(1):69
pubmed: 35331308
Dig Dis Sci. 2000 May;45(5):987-97
pubmed: 10795765
Blood Coagul Fibrinolysis. 2016 Jun;27(4):361-4
pubmed: 26588445
Braz J Anesthesiol. 2018 May - Jun;68(3):238-243
pubmed: 29269148
J Clin Invest. 1985 May;75(5):1463-70
pubmed: 2860124
Semin Thromb Hemost. 1996;22(5):445-50
pubmed: 8989829
Transfus Apher Sci. 2018 Dec;57(6):700-704
pubmed: 30087086
Dermatol Surg. 2002 Nov;28(11):1098-9
pubmed: 12460316
Burns. 2013 Sep;39(6):1157-61
pubmed: 23498713
Thromb Res. 1999 Jun 1;94(5):271-305
pubmed: 10379818

Auteurs

Florian Bucher (F)

Department of Plastic, Aesthetic, Hand, and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.

Nadjib Dastagir (N)

Department of Plastic, Aesthetic, Hand, and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.

Doha Obed (D)

Department of Plastic, Aesthetic, Hand, and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.

Anieto Enechukwu (A)

Department of Plastic, Aesthetic, Hand, and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.

Thorben Dieck (T)

Department of Plastic, Aesthetic, Hand, and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.

Peter M Vogt (PM)

Department of Plastic, Aesthetic, Hand, and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.

Khaled Dastagir (K)

Department of Plastic, Aesthetic, Hand, and Reconstructive Surgery, Hannover Medical School, Hannover, Germany.

Classifications MeSH